• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015年以色列人群中腮腺炎和风疹血清阳性的一致性

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015.

作者信息

Bassal Ravit, Shohat Tamy, Levin Tal, Pando Rakefet, Shinar Eilat, Amichay Doron, Barak Mira, Ben-Dor Anat, Bar-Haim Adina, Mendelson Ella, Cohen Dani, Keinan-Boker Lital, Indenbaum Victoria

机构信息

Israel Center for Disease Control, Ministry of Health, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.

Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

出版信息

Vaccines (Basel). 2022 Jun 22;10(7):996. doi: 10.3390/vaccines10070996.

DOI:10.3390/vaccines10070996
PMID:35891160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9319066/
Abstract

Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years. We assessed the sero-prevalence of mumps and rubella, identified factors associated with sero-negativity, and evaluated concordance between mumps and rubella sero-positivity. A national cross-sectional sero-survey was conducted on samples collected in 2015 by the Israel National Sera Bank. Samples were tested for mumps and rubella IgG antibodies using an enzyme-linked immunosorbent assay. Of 3131 samples tested for mumps IgG, 84.8% (95%CI: 83.5-86.0%) were sero-positive. Sero-negativity for mumps was significantly associated with age (high odds ratios observed in infants younger than 4 years and 20-29 years old subjects). Of 3169 samples tested for rubella IgG antibodies, 95.2% (95%CI: 94.4-95.9%) were sero-positive. Rubella sero-negativity was significantly associated with age (high odds ratios observed in children younger than 4 years old and adults older than 30 years), males, Jews, and others. Concordant sero-positivity for both mumps and rubella viruses was observed in 83.9% of the tested samples. The Israeli population was sufficiently protected against rubella but not against mumps. Since both components are administered in the MMRV vaccine simultaneously, the mumps component has a lower uptake than rubella and quicker waning.

摘要

腮腺炎和风疹是可通过麻疹-腮腺炎-风疹-水痘(MMRV)疫苗预防的病毒性疾病,该疫苗在12个月大时接种一次,6岁时再次接种。我们评估了腮腺炎和风疹的血清流行率,确定了与血清阴性相关的因素,并评估了腮腺炎和风疹血清阳性之间的一致性。对以色列国家血清库2015年收集的样本进行了全国性横断面血清调查。使用酶联免疫吸附测定法检测样本中的腮腺炎和风疹IgG抗体。在3131份检测腮腺炎IgG的样本中,84.8%(95%CI:83.5-86.0%)为血清阳性。腮腺炎血清阴性与年龄显著相关(在4岁以下婴儿和20-29岁受试者中观察到高比值比)。在3169份检测风疹IgG抗体的样本中,95.2%(95%CI:94.4-95.9%)为血清阳性。风疹血清阴性与年龄(在4岁以下儿童和30岁以上成年人中观察到高比值比)、男性、犹太人及其他因素显著相关。在83.9%的检测样本中观察到腮腺炎和风疹病毒的血清阳性一致。以色列人群对风疹有足够的免疫力,但对腮腺炎则不然。由于MMRV疫苗中的两种成分同时接种,腮腺炎成分的接种率低于风疹,且抗体消退更快。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ec/9319066/980ac9500917/vaccines-10-00996-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ec/9319066/7dc97df2bb6d/vaccines-10-00996-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ec/9319066/980ac9500917/vaccines-10-00996-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ec/9319066/7dc97df2bb6d/vaccines-10-00996-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ec/9319066/980ac9500917/vaccines-10-00996-g002.jpg

相似文献

1
The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015.2015年以色列人群中腮腺炎和风疹血清阳性的一致性
Vaccines (Basel). 2022 Jun 22;10(7):996. doi: 10.3390/vaccines10070996.
2
[Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].[马德里学童中麻疹、风疹、腮腺炎和水痘抗体的血清流行率]
An Esp Pediatr. 1999 May;50(5):459-62.
3
Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants.印度婴儿的麻疹、腮腺炎、风疹和水痘抗体的早期消失。
Vaccine. 2019 Mar 7;37(11):1443-1448. doi: 10.1016/j.vaccine.2019.01.043. Epub 2019 Feb 11.
4
Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.健康儿童接种两剂四价麻疹-腮腺炎-风疹-水痘疫苗后 3 年的抗体持久性。
Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21.
5
[Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life].[出生后前六个月婴儿母亲的麻疹、风疹、腮腺炎及水痘抗体患病率]
Mikrobiyol Bul. 2018 Jul;52(3):324-327. doi: 10.5578/mb.67169.
6
Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.5至6岁健康儿童接种第二剂麻疹-腮腺炎-风疹-水痘疫苗的免疫原性和安全性
Pediatr Infect Dis J. 2007 Feb;26(2):153-8. doi: 10.1097/01.inf.0000250689.09396.21.
7
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).使用麻疹、腮腺炎、风疹和水痘联合疫苗:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.
8
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.四价麻疹-腮腺炎-风疹-水痘疫苗与结合型C群脑膜炎球菌疫苗联合接种于健康儿童时的免疫原性和安全性:意大利一项IIIb期、随机、多中心研究
Vaccine. 2016 Aug 5;34(36):4278-84. doi: 10.1016/j.vaccine.2016.07.009. Epub 2016 Jul 14.
9
Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.一种减毒活四价麻疹-腮腺炎-风疹-水痘(MMRV)疫苗的反应原性和免疫原性。
Vaccine. 2002 Dec 13;21(3-4):281-9. doi: 10.1016/s0264-410x(02)00459-0.
10
Combination measles, mumps, rubella and varicella vaccine.麻疹、腮腺炎、风疹和水痘联合疫苗
Pediatrics. 1986 Oct;78(4 Pt 2):742-7.

引用本文的文献

1
Rubella seroprevalence among unvaccinated school-aged children in Jos, North Central, Nigeria.尼日利亚中北部乔斯未接种疫苗学龄儿童的风疹血清流行率。
Pan Afr Med J. 2024 Sep 2;49:1. doi: 10.11604/pamj.2024.49.1.44172. eCollection 2024.
2
Serosurveillance for Measles and Rubella.麻疹和风疹血清学监测
Vaccines (Basel). 2024 Jul 22;12(7):816. doi: 10.3390/vaccines12070816.

本文引用的文献

1
The Israel National Sera Bank: Methods, Representativeness, and Challenges.以色列国家血清银行:方法、代表性和挑战。
Int J Environ Res Public Health. 2021 Feb 25;18(5):2280. doi: 10.3390/ijerph18052280.
2
Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.流行性腮腺炎:暴发、疫苗效力和基因组多样性的最新研究进展
Clin Microbiol Rev. 2020 Feb 26;33(2). doi: 10.1128/CMR.00151-19. Print 2020 Mar 18.
3
Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
中国上海城区 20 年麻腮风疫苗接种后腮腺炎抗体的血清阳性率及相关决定因素。
Int J Environ Res Public Health. 2018 Sep 23;15(10):2089. doi: 10.3390/ijerph15102089.
4
Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.2018 年和 2020 年法国麻疹、腮腺炎和风疹的再现风险。
Euro Surveill. 2018 Jun;23(25). doi: 10.2807/1560-7917.ES.2018.23.25.1700796.
5
Australian rubella serosurvey 2012-2013: On track for elimination?澳大利亚风疹血清学调查 2012-2013 年:是否有望消除?
Vaccine. 2018 May 11;36(20):2794-2798. doi: 10.1016/j.vaccine.2018.03.086. Epub 2018 Apr 13.
6
Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.麻疹、腮腺炎和风疹抗体持久性模式及 MMR 疫苗第二剂接种后的下降速度。
Vaccine. 2018 Feb 1;36(6):818-826. doi: 10.1016/j.vaccine.2017.12.075. Epub 2018 Jan 6.
7
Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy.捷克共和国成年人腮腺炎抗体的血清学调查及疫苗接种策略的改变需求。
Hum Vaccin Immunother. 2018 Apr 3;14(4):887-893. doi: 10.1080/21645515.2017.1412021. Epub 2018 Jan 16.
8
Humoral immunity to mumps in a highly vaccinated population in Taiwan.台湾高度接种疫苗人群中对腮腺炎的体液免疫。
J Microbiol Immunol Infect. 2019 Jun;52(3):379-385. doi: 10.1016/j.jmii.2017.09.001. Epub 2017 Oct 7.
9
Analysis of sparse data in logistic regression in medical research: A newer approach.医学研究中逻辑回归稀疏数据的分析:一种新方法。
J Postgrad Med. 2016 Jan-Mar;62(1):26-31. doi: 10.4103/0022-3859.173193.
10
Seroprevalence of mumps in an epidemic period in Medellín, Colombia.哥伦比亚麦德林市疫情期间腮腺炎的血清流行率。
Vaccine. 2015 Oct 13;33(42):5606-5612. doi: 10.1016/j.vaccine.2015.08.088. Epub 2015 Sep 10.